GEN inCode

Safeguarding your future health with predictive genetics

GEN inCode products combine genetic and clinical data to risk assess patients and provide healthcare practitioners with advanced clinical information to evaluate and predict the onset of cardiovascular disease. GEN inCode predictive technology provides patients and physicians with globally leading preventative care and treatment strategies. the molecular tests combine clinical algorithms and artificial intelligence to provide advanced patient risk assessment to predict disease onset and clinical information to determine the most effective treatment pathway (precision medicine).

Key facts

Sector - Healthcare

When Downing first invested - 2019

Website -